Searched for
GSK AUSTRALIA
US stocks tick higher as investors look past hawkish talk, await shutdown clarityU.S. stocks rose Monday, recovering recent losses, despite looming government shutdown fears and new tariffs. Electronic Arts jumped on a $...- European Commission authorises GSK's HIV prevention drugCabotegravir is recommended in combination with safer sex practices for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually-acqu...
- Aussie buoyant, dollar listless as Omicron optimism lifts risk assetsThe Australian dollar hit its strongest level in a week on Wednesday amid a pick-up in risk appetite on signs Omicron may be less severe th...
- GSK, Sanofi say COVID-19 shot won't be ready until late 2021The companies said early trials showed the vaccine produced an "insufficient" immune response in older adults, demonstrating the need to re...
- Stocks in the news: Wipro, RIL, Hindalco, HDFC, Tata Steel, Welspun Corp and BioconIT major Wipro will announce its fourth-quarter and FY20 results today.
- Hilleman Labs, NICED to develop Shigella VaccineThe two aim to complete the development of this vaccine by 2024, according to Hilleman Labs chief executive officer Davinder Gill.
- GSK Healthcare banks on Sensodyne, Crocin to drive growth in IndiaIn India, the power brands will be Sensodyne, Panadol (called Crocin in India), nasal decongestant Otrivin and Voltaren pain relieving gels...
- Sun Pharma bids to acquire InSite Vision IncSources close to the transaction have indicated that Sun Pharma has already bid for US OTC Market listed Insite Vision for Rs 300 cr.
- Carlyle to buy 37% stake in diagnostics chain MetropolisGlobal private equity fund Carlyle is buying 37% stake in diagnostics chain Metropolis from one of its founders GSK Velu.
- Sun Pharma completes acquisition of GSK Australia opiates businessDrug major Sun Pharmaceutical Industries has completed the acquisition of GlaxoSmithKline's opiates business in Australia.
- Back in India, GSK Consumer Healthcare’s Manoj Kumar will have to adapt to a different trade modelExperts say while his global experience will be an advantage, it will require a lot more in pushing sales of Horlicks.
- GSK Consumer Q4 Net up 14.60 pc at Rs 196.78 croreGlaxoSmithkline (GSK) Consumer Healthcare Ltd today reported a 14.60 per cent increase in net profit at Rs 196.78 crore for the fourth quar...
- Former P&G Executive Manoj Kumar may succeed GSK Consumer MD AhmedUnder the new structure, Ahmed will be overseeing operations in more than 100 countries. It could not be confirmed if Ahmed would continue ...
- Sun Pharma hits fresh 52-week high, gains over 8% intraday on plans to buy GSK unitThe global Opiates market holds good potential and the addition of GSK’s Opiates business will strengthen Sun's positioning further, says A...
- Sun Pharma acquires GSK's opiates business in Australia as part of niche foray strategyThe acquisition will give Sun a product portfolio consisting of poppy-derived opiate raw material — mainly used to make painkillers.
- GSK Consumer Healthcare Zubair Ahmed appointed head of Asia Pacific, Middle East and Africa regionAs part of the new role, Ahmed will oversee operations of over 100 countries, joining the growing league of Indians taking on top roles glo...
- Australian ruling on cigarette packages burns ITC, FMCG stocksShares of tobacco-to-hospitality major ITC fell 3.6% to 258 on Thursday after the Australian Supreme Court on Wednesday banned logos on cig...
- Strides Arcolab may fetch Rs 1250 cr from sale of domestic unitsStrides has received offers from a variety of global generic drug manufacturers as well as some Indian drug-makers and PE funds for the bus...
- GSK to invest Rs 270 cr in 3 years: McPhersonGlaxoSmithKline Consumer Healthcare, makers of Horlicks, Boost and Crocin brands, will invest more than Rs 270 crore ($61 million) in its I...
- DHL Global Forwarding realigns operationsDHL plans to restructure its high growth Asia-Pacific operations to provide customised solutions through an integrated structure.
Load More
